Bengaluru: Ecron Acunova (EA), a fully owned subsidiary of TAKE Solutions and a globally recognized full service CRO with Clinical and BA/BE expertise, has announced that it would be consolidating its capabilities with TAKE’s niche Life Sciences brand Navitas and Intelent to form a unified go-to-market entity – Navitas Life Sciences.
EA’s significant Clinical capabilities, having conducted over 1300 studies including BA/BE, NIS, and phase II – IV in its state-of-the-art and audited facilities, will be augmented by legacy brands Navitas’s technology led solutions across Clinical, Regulatory and Safety, and Intelent’s big data and analytics expertise to form the 360 degree service provider Navitas Life Sciences. The unified Navitas Life Sciences will serve as an end-to-end strategic partner for Life Sciences companies to help them address their critical challenges and achieve their desired outcomes.
The Chennai-based life sciences technology provider, Take Solutions, had stepped deeper into life sciences technology during 2015, with the acquisition of Bengaluru-based Ecron Acunova in an all-cash Rs 115-crore deal.
The Manipal Group and US-based PE fund OrbiMed, the owners at that time had exited Ecron through the deal. Orginally, the Ecron Akunova was an Indo-German collaborative effort. The Manipal Group’s Manipal Acunova had acquired Germany-based Ecron in 2007 to form Ecron Acunova, a clinical research organisation. It has facilities in Bengaluru, Mangalore and Manipal and a lot of access to Manipal’s hospitals.
The unified Navitas Life Sciences will serve as an end-to-end strategic partner for Life Sciences companies to help them address their critical challenges and achieve their desired outcomes.
